XML 176 R55.htm IDEA: XBRL DOCUMENT
v3.22.2

Segmental information - Consolidated income statement (Details) - GBP (£) £ in Millions | 12 Months Ended
--- | ---
Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2020
Disclosure of operating segments [line items] |  |  |
Sales | £ 22,448 | £ 19,153 | £ 17,697
Net sales |  |  |
At budgeted exchange rates | 15,411 | 13,483 | 11,579
Acquisitions and disposals | 75 | 35 | 93
SC&P allocation | 0 | 0 | 0
Retranslation to actual exchange rates | (223) | (785) | 80
Hyper Related Adjustment In Respect Of Net Sales | 189 |  |
Net sales | 15,452 | 12,733 | 11,752
Operating profit/(loss) |  |  |
At budgeted exchange rates | 4,773 | 4,160 | 3,498
Acquisitions and disposals | (27) | (21) | (5)
SC&P allocation | 0 | 0 | 0
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 65 | (36) |
Fair value remeasurement of contingent consideration |  |  | (7)
Fair value remeasurement of biological assets | (5) |  | 9
Retranslation to actual exchange rates | (19) | (357) | (1)
Hyperinflation | 10 |  |
Operating profit/(loss) before exceptional items | 4,797 | 3,746 | 3,494
Exceptional items | (388) | (15) | (1,357)
Operating profit/(loss) | 4,409 | 3,731 | 2,137
Non-operating items | (17) | 14 | (23)
Net finance charges | (422) | (373) | (353)
Share of after tax results of associates and joint ventures |  |  |
Share of after tax results of associates and joint ventures | 417 | 334 | 282
Profit before taxation | £ 4,387 | 3,706 | 2,043
Annual net sales occur in the last four months | 37.00% |  |
Moet Hennessy |  |  |
Net sales |  |  |
Net sales | £ 5,553 | 4,819 | 4,425
Share of after tax results of associates and joint ventures |  |  |
Share of after tax results of associates and joint ventures | 425 | 335 | 285
Other |  |  |
Share of after tax results of associates and joint ventures |  |  |
Share of after tax results of associates and joint ventures | (8) | (1) | (3)
Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 22,394 | 19,133 | 17,659
Net sales |  |  |
At budgeted exchange rates | 15,356 | 13,463 | 11,541
Acquisitions and disposals | 75 | 35 | 93
SC&P allocation | 0 | 0 | (1)
Retranslation to actual exchange rates | (222) | (785) | 81
Hyper Related Adjustment In Respect Of Net Sales | 189 |  |
Net sales | 15,398 | 12,713 | 11,714
Operating profit/(loss) |  |  |
At budgeted exchange rates | 5,029 | 4,378 | 3,650
Acquisitions and disposals | (27) | (21) | (5)
SC&P allocation | 0 | 0 | 0
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 65 | (36) |
Fair value remeasurement of contingent consideration |  |  | (7)
Fair value remeasurement of biological assets | (5) |  | 9
Retranslation to actual exchange rates | (37) | (367) | (6)
Hyperinflation | 10 |  |
Operating profit/(loss) before exceptional items | 5,035 | 3,954 | 3,641
Exceptional items | (388) | (15) | (1,357)
Operating profit/(loss) | 4,647 | 3,939 | 2,284
Operating segments | North America |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 6,682 | 5,803 | 5,222
Net sales |  |  |
At budgeted exchange rates | 5,955 | 5,527 | 4,445
Acquisitions and disposals | 34 | 28 | 32
SC&P allocation | 9 | 9 | 11
Retranslation to actual exchange rates | 97 | (355) | 135
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | 6,095 | 5,209 | 4,623
Operating profit/(loss) |  |  |
At budgeted exchange rates | 2,388 | 2,469 | 2,007
Acquisitions and disposals | (28) | (18) | (1)
SC&P allocation | (1) | (30) | 6
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 32 | (9) |
Fair value remeasurement of contingent consideration |  |  | (10)
Fair value remeasurement of biological assets | 0 |  | 0
Retranslation to actual exchange rates | 63 | (175) | 32
Hyperinflation | 0 |  |
Operating profit/(loss) before exceptional items | 2,454 | 2,237 | 2,034
Exceptional items | (1) | 0 | 54
Operating profit/(loss) | 2,453 | 2,237 | 2,088
Operating segments | Europe |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 5,740 | 4,795 | 4,697
Net sales |  |  |
At budgeted exchange rates | 3,258 | 2,579 | 2,501
Acquisitions and disposals | 23 | 2 | 10
SC&P allocation | 46 | 45 | 60
Retranslation to actual exchange rates | (304) | (68) | (4)
Hyper Related Adjustment In Respect Of Net Sales | 189 |  |
Net sales | 3,212 | 2,558 | 2,567
Operating profit/(loss) |  |  |
At budgeted exchange rates | 1,086 | 728 | 730
Acquisitions and disposals | 11 | (3) | (4)
SC&P allocation | (18) | (32) | 26
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 36 | (27) |
Fair value remeasurement of contingent consideration |  |  | (4)
Fair value remeasurement of biological assets | 0 |  | 0
Retranslation to actual exchange rates | (108) | (31) | 9
Hyperinflation | 10 |  |
Operating profit/(loss) before exceptional items | 1,017 | 635 | 757
Exceptional items | (146) | (15) | (62)
Operating profit/(loss) | 871 | 620 | 695
Operating segments | Asia Pacific |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 5,624 | 5,146 | 4,645
Net sales |  |  |
At budgeted exchange rates | 2,879 | 2,561 | 2,253
Acquisitions and disposals | 0 | 0 | 1
SC&P allocation | 9 | 9 | 12
Retranslation to actual exchange rates | (4) | (82) | 4
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | 2,884 | 2,488 | 2,270
Operating profit/(loss) |  |  |
At budgeted exchange rates | 703 | 628 | 498
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | (2) | (5) | 6
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 0 | 0 |
Fair value remeasurement of contingent consideration |  |  | 0
Fair value remeasurement of biological assets | 0 |  | 0
Retranslation to actual exchange rates | 10 | (15) | (3)
Hyperinflation | 0 |  |
Operating profit/(loss) before exceptional items | 711 | 608 | 501
Exceptional items | (241) | 0 | (1,198)
Operating profit/(loss) | 470 | 608 | (697)
Operating segments | Africa |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 2,403 | 2,020 | 1,911
Net sales |  |  |
At budgeted exchange rates | 1,699 | 1,541 | 1,300
Acquisitions and disposals | 15 | 5 | 50
SC&P allocation | 3 | 3 | 4
Retranslation to actual exchange rates | (35) | (137) | (8)
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | 1,682 | 1,412 | 1,346
Operating profit/(loss) |  |  |
At budgeted exchange rates | 346 | 228 | 116
Acquisitions and disposals | (10) | 0 | 0
SC&P allocation | (1) | (3) | 2
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 0 | 0 |
Fair value remeasurement of contingent consideration |  |  | 0
Fair value remeasurement of biological assets | 0 |  | 0
Retranslation to actual exchange rates | (20) | (54) | (17)
Hyperinflation | 0 |  |
Operating profit/(loss) before exceptional items | 315 | 171 | 101
Exceptional items | 0 | 0 | (145)
Operating profit/(loss) | 315 | 171 | (44)
Operating segments | Latin America and Caribbean |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 1,945 | 1,369 | 1,184
Net sales |  |  |
At budgeted exchange rates | 1,486 | 1,176 | 944
Acquisitions and disposals | 3 | 0 | 0
SC&P allocation | 12 | 13 | 10
Retranslation to actual exchange rates | 24 | (143) | (46)
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | 1,525 | 1,046 | 908
Operating profit/(loss) |  |  |
At budgeted exchange rates | 528 | 422 | 254
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | 0 | (27) | 5
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | (3) | 0 |
Fair value remeasurement of contingent consideration |  |  | 7
Fair value remeasurement of biological assets | (5) |  | 9
Retranslation to actual exchange rates | 18 | (92) | (27)
Hyperinflation | 0 |  |
Operating profit/(loss) before exceptional items | 538 | 303 | 248
Exceptional items | 0 | 0 | (6)
Operating profit/(loss) | 538 | 303 | 242
Operating segments | SC&P |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 2,010 | 1,537 | 1,343
Net sales |  |  |
At budgeted exchange rates | 2,095 | 1,627 | 1,439
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | (79) | (79) | (98)
Retranslation to actual exchange rates | (6) | (11) | 2
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | 2,010 | 1,537 | 1,343
Operating profit/(loss) |  |  |
At budgeted exchange rates | (22) | (97) | 45
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | 22 | 97 | (45)
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 0 | 0 |
Fair value remeasurement of contingent consideration |  |  | 0
Fair value remeasurement of biological assets | 0 |  | 0
Retranslation to actual exchange rates | 0 | 0 | 0
Hyperinflation | 0 |  |
Operating profit/(loss) before exceptional items | 0 | 0 | 0
Exceptional items | 0 | 0 | 0
Operating profit/(loss) | 0 | 0 | 0
Elimination of intersegment sales |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | (2,010) | (1,537) | (1,343)
Net sales |  |  |
At budgeted exchange rates | (2,016) | (1,548) | (1,341)
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | 0 | 0 | 0
Retranslation to actual exchange rates | 6 | 11 | (2)
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | (2,010) | (1,537) | (1,343)
Corporate and other |  |  |
Disclosure of operating segments [line items] |  |  |
Sales | 54 | 20 | 38
Net sales |  |  |
At budgeted exchange rates | 55 | 20 | 38
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | 0 | 0 | 1
Retranslation to actual exchange rates | (1) | 0 | (1)
Hyper Related Adjustment In Respect Of Net Sales | 0 |  |
Net sales | 54 | 20 | 38
Operating profit/(loss) |  |  |
At budgeted exchange rates | (256) | (218) | (152)
Acquisitions and disposals | 0 | 0 | 0
SC&P allocation | 0 | 0 | 0
Fair value remeasurement of contingent considerations, equity option and earn out arrangements | 0 | 0 |
Fair value remeasurement of contingent consideration |  |  | 0
Fair value remeasurement of biological assets | 0 |  | 0
Retranslation to actual exchange rates | 18 | 10 | 5
Hyperinflation | 0 |  |
Operating profit/(loss) before exceptional items | (238) | (208) | (147)
Exceptional items | 0 | 0 | 0
Operating profit/(loss) | £ (238) | £ (208) | £ (147)

X
- Definition Acquisitions and disposals included in net sales. + References No definition available. + Details
Name: | deo_AcquisitionsAndDisposalsIncludedInNetSales
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Acquisitions and disposals included in operating profit loss before exceptional items. + References No definition available. + Details
Name: | deo_AcquisitionsAndDisposalsIncludedInOperatingProfitLossBeforeExceptionalItems
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Exceptional operating items included in operating profit loss. + References No definition available. + Details
Name: | deo_ExceptionalOperatingItemsIncludedInOperatingProfitLoss
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition fair value remeasurement of biological assets in operating profit + References No definition available. + Details
Name: | deo_Fairvalueremeasurementofbiologicalassetsinoperatingprofit
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Gains (Losses) On Fair Value Remeasurement Of Contingent Consideration + References No definition available. + Details
Name: | deo_GainsLossesOnFairValueRemeasurementOfContingentConsideration
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Gains (Losses) On Fair Value Remeasurement Of Contingent Considerations, Equity Option And Earn Out Arrangements + References No definition available. + Details
Name: | deo_GainsLossesOnFairValueRemeasurementOfContingentConsiderationsEquityOptionAndEarnOutArrangements
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Hyper Related Adjustement Of Operating Profit/Loss Before Exceptional + References No definition available. + Details
Name: | deo_HyperRelatedAdjustementOfOperatingProfitLossBeforeExceptional
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Hyper Related Adjustment In Respect Of Net Sales + References No definition available. + Details
Name: | deo_HyperRelatedAdjustmentInRespectOfNetSales
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Net sales + References No definition available. + Details
Name: | deo_NetSales
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Net sales information of segment. + References No definition available. + Details
Name: | deo_NetSalesInformationOfSegmentAbstract
Namespace Prefix: | deo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Non operating gains losses. + References No definition available. + Details
Name: | deo_NonOperatingGainsLosses
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Operating profit loss before exceptional items at budgeted exchange rates. + References No definition available. + Details
Name: | deo_OperatingProfitLossAtBudgetedExchangeRatesBeforeExceptionalItems
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of gross profit less marketing,other operating expenses and exceptional items. + References No definition available. + Details
Name: | deo_OperatingProfitLossBeforeExceptionalItems
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Operating profit (loss) information of segment. + References No definition available. + Details
Name: | deo_OperatingProfitLossInformationOfSegmentAbstract
Namespace Prefix: | deo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of annual net sales. + References No definition available. + Details
Name: | deo_PercentageOfAnnualNetSales
Namespace Prefix: | deo_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Retranslation of net sales to actual exchange rates. + References No definition available. + Details
Name: | deo_RetranslationOfNetSalesToActualExchangeRates
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Retranslation of operating profit loss before exceptional items to actual exchange rates. + References No definition available. + Details
Name: | deo_RetranslationOfOperatingProfitLossBeforeExceptionalItemsToActualExchangeRates
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Revenue from sales net at budgeted exchange rates. + References No definition available. + Details
Name: | deo_RevenueFromSalesNetAtBudgetedExchangeRates
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Share of after tax results of associates and joint ventures. + References No definition available. + Details
Name: | deo_ShareOfAfterTaxResultsOfAssociatesAndJointVenturesAbstract
Namespace Prefix: | deo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Supply Chain and Procurement allocation of net sales to operating segments. + References No definition available. + Details
Name: | deo_SupplyChainAndProcurementAllocationOfNetSales
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Supply Chain and Procurement allocation of operating profit loss before exceptional items. + References No definition available. + Details
Name: | deo_SupplyChainAndProcurementAllocationOfOperatingProfitLossBeforeExceptionalItems
Namespace Prefix: | deo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of income or cost associated with interest and other financing activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 85 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_FinanceIncomeCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 28 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 103 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 102 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard -URIDate 2021-03-24 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2021-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ProfitLossBeforeTax
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 32 -IssueDate 2021-01-01 -Paragraph IE33 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 85 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ProfitLossFromOperatingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 28 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 32 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 33 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard -URIDate 2021-03-24 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 34 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard -URIDate 2021-03-24 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard -URIDate 2021-03-24 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 103 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard -URIDate 2021-03-24 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 102 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard -URIDate 2021-03-24 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2021-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2021-03-24 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B12 -Subparagraph b -Clause v -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B -URIDate 2021-03-24 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B10 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2021-03-24 + Details
Name: | ifrs-full_Revenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -Subparagraph g -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_g&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 28 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective on first application of IFRS 9 -Name IFRS -Number 4 -IssueDate 2021-01-01 -Paragraph 39M -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M_b&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_c&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=deo_MoetHennessyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=deo_OtherAssociatesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=deo_NorthAmericaSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=deo_EuropeSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=deo_AsiaPacificSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=deo_AfricaSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=deo_LatinAmericaAndCaribbeanSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=deo_SupplyChainAndProcurementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_EliminationOfIntersegmentAmountsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_UnallocatedAmountsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |